Peptide therapy is not intended to diagnose, treat, cure, or prevent any disease and should not replace evaluation or treatment by a licensed medical professional
It has never been FDA-approved as a drug for any indication, and the absence of a completed phase III trial program means rare, long-term adverse events (including any cancer signal) may not yet be fully characterized in the way they would be for an approved compound
Injectable GLP-1 medications are administered via subcutaneous injection, typically weekly
however, the NK cell pool exhibits phenotypic and functional heterogeneity, and the antibody--mediated effect of NK cells remains less characterized
Commonly recognized side effects, such as gastrointestinal symptoms, were also widely reported, lending credibility to the approach
The Critical Distinction: Mechanism and Magnitude It's essential to understand that probiotic GLP-1 supplements work through fundamentally different mechanisms than pharmaceutical medications